Vertex Pharmaceuticals Incorporated (VRTX) Q2 2025 Earnings Call Transcript
Summary
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Pa...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Charles F. Wagner - Executive VP, COO & CFO Duncan McKechnie - Corporate Participant Reshma Kewalramani - CEO, President & Director Susie Lisa - Senior Vice President of Investor Relations Conference Call Participants David Reed Risinger - Leerink Partners LLC, Research Division Divya Rao - TD Cowen, Research Division Eliana Rachel Merle - UBS Investment Bank, Research Division Evan David Seigerman - BMO Capital Markets Equity Research Geoffrey Christopher Meacham - Citigroup Inc., Research Division Jessica Macomber Fye - JPMorgan Chase & Co, Research Division Mohit Bansal - Wells Fargo Securities, LLC, Research Division Salveen Jaswal Richter - Goldman Sachs Group, Inc., Research Division Tazeen Ahmad - BofA Securities, Research Division Terence C.